chr4:1806119:G>A Detail (hg19) (FGFR3)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr4:1,806,119-1,806,119 |
hg38 | chr4:1,804,392-1,804,392 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_001163213.1:c.1144G>A | NP_001156685.1:p.Gly382Arg |
NM_022965.3:c.1126G>A | NP_075254.1:p.Gly376Arg | |
NM_000142.4:c.1138G>A | NP_000133.1:p.Gly380Arg |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 2 |
GWAS entry | |
Disease area statistics | Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
2020/04/20 | bronchus or lung, unspecified |
![]() |
MGS000041
(TMGS000094) |
Hitoshi Nakagama | National Cancer Center Japan | |||
![]() |
other |
![]() |
MGS000001
(TMGS000138) |
Kenjiro Kosaki | Keio University |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2024-03-14 | criteria provided, multiple submitters, no conflicts | achondroplasia |
![]() ![]() ![]() |
Detail |
![]() |
2006-02-01 | no assertion criteria provided | achondroplasia |
![]() |
Detail |
![]() |
2011-04-15 | no assertion criteria provided | epidermal nevus |
![]() |
Detail |
![]() |
2024-01-29 | criteria provided, multiple submitters, no conflicts | not provided |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2018-10-31 | criteria provided, single submitter | Carcinoma of colon,Malignant tumor of urinary bladder,cervical cancer,achondroplasia,hypochondroplasia,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,epidermal nevus,Muenke Syndrome,Crouzon syndrome-acanthosis nigricans syndrome,camptodactyly-tall stature-scoliosis-hearing loss syndrome,Levy-Hollister syndrome,Thanatophoric dysplasia, type 2,Malignant tumor of testis,Thanatophoric dysplasia type 1 |
![]() |
Detail |
![]() |
2022-03-29 | criteria provided, single submitter | Inborn genetic diseases |
![]() |
Detail |
![]() |
2020-07-28 | criteria provided, single submitter | not specified |
![]() |
Detail |
![]() |
2022-05-09 | criteria provided, multiple submitters, no conflicts | hypochondroplasia |
![]() |
Detail |
![]() |
2022-07-19 | criteria provided, single submitter | Connective tissue disorder |
![]() |
Detail |
![]() |
2023-05-08 | criteria provided, single submitter | camptodactyly-tall stature-scoliosis-hearing loss syndrome |
![]() |
Detail |
![]() |
criteria provided, single submitter | FGFR3-related disorder |
![]() |
Detail |
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.002 | chondrosarcoma | Meclozine also ameliorated abnormally suppressed proliferation of human chondros... | BeFree | 24324705 | Detail |
<0.001 | chondrosarcoma | Meclozine also ameliorated abnormally suppressed proliferation of human chondros... | BeFree | 24324705 | Detail |
0.002 | chondrosarcoma | Meclozine also ameliorated abnormally suppressed proliferation of human chondros... | BeFree | 24324705 | Detail |
0.621 | achondroplasia | NA | CLINVAR | Detail | |
0.362 | NEVUS, EPIDERMAL (disorder) | NA | CLINVAR | Detail | |
0.621 | achondroplasia | Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the... | BeFree | 9780920 | Detail |
0.010 | ACROCEPHALOPOLYSYNDACTYLY TYPE IV | Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the... | BeFree | 9780920 | Detail |
0.332 | Pfeiffer syndrome | Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the... | BeFree | 9780920 | Detail |
0.009 | Dwarfism | Achondroplasia, the most common form of dwarfism in man, is a dominant genetic d... | BeFree | 10200283 | Detail |
0.621 | achondroplasia | A recurrent glycine to arginine mutation at codon 380 (G380R) in the transmembra... | BeFree | 10979354 | Detail |
0.621 | achondroplasia | We developed a quantitative fluorescent-polymerase chain reaction (QF-PCR) metho... | BeFree | 20963478 | Detail |
0.007 | Skeletal dysplasia | Achondroplasia is a skeletal dysplasia caused by substitution of arginine for gl... | BeFree | 11472579 | Detail |
0.269 | multiple myeloma | Although not at the G1138A site, there are increased rates of other somatic muta... | BeFree | 19551630 | Detail |
0.621 | achondroplasia | The mother has achondroplasia and carries the common G1138 (G380R) mutation in t... | BeFree | 10360393 | Detail |
0.009 | Dwarfism | The G380R mutation in FGFR3 transmembrane domain is known as the genetic cause f... | BeFree | 20624921 | Detail |
0.621 | achondroplasia | Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gen... | BeFree | 12921294 | Detail |
0.621 | achondroplasia | Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondropla... | BeFree | 18199430 | Detail |
0.621 | achondroplasia | FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: ph... | BeFree | 10881785 | Detail |
0.621 | achondroplasia | The father has achondroplasia due to the common G1138A (G380R) mutation in the f... | BeFree | 10360392 | Detail |
0.621 | achondroplasia | We propose that the achondroplasia mutation G380R uncouples ligand-mediated rece... | UNIPROT | 10611230 | Detail |
0.621 | achondroplasia | A glycine to arginine mutation at codon 380 (G380R) of the fibroblast growth fac... | BeFree | 11556601 | Detail |
0.495 | Hypochondroplasia (disorder) | The father has achondroplasia due to the common G1138A (G380R) mutation in the f... | BeFree | 10360392 | Detail |
0.621 | achondroplasia | Rapid detection of G1138A and G1138C mutations of the FGFR3 gene in patients wit... | BeFree | 22339077 | Detail |
0.495 | Hypochondroplasia (disorder) | To determine whether the genotype could be distinguished on the basis of the phe... | BeFree | 9853502 | Detail |
0.621 | achondroplasia | Achondroplasia in Sweden caused by the G1138A mutation in FGFR3. | BeFree | 9001669 | Detail |
0.621 | achondroplasia | Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead'... | BeFree | 12297284 | Detail |
0.009 | Dwarfism | The Gly380Arg mutation in FGFR3 is the genetic cause for achondroplasia (ACH), t... | BeFree | 23056398 | Detail |
0.621 | achondroplasia | Furthermore, a G380R mutation in FGFR3 (FGFR3(Ach)), which results in achondropl... | BeFree | 17466614 | Detail |
0.621 | achondroplasia | The most common mutation for achondroplasia (FGFR3 Gly380Arg, resulting in 1138G... | BeFree | 21739570 | Detail |
0.621 | achondroplasia | Our results support the argument that the G380R mutation of FGFR-3 is the most f... | BeFree | 8682509 | Detail |
0.621 | achondroplasia | The most common G380R FGFR3 achondroplasia mutation was detected. | BeFree | 16475234 | Detail |
0.362 | NEVUS, EPIDERMAL (disorder) | The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouple... | UNIPROT | 10611230 | Detail |
0.621 | achondroplasia | Down syndrome and achondroplasia were confirmed by karyotyping and presence of a... | BeFree | 18196933 | Detail |
0.621 | achondroplasia | The most common achondroplasia mutation, a p.Gly380Arg in the fibroblast growth ... | BeFree | 23949953 | Detail |
0.621 | achondroplasia | A mouse model for achondroplasia was generated by introducing the human mutation... | BeFree | 11518810 | Detail |
0.621 | achondroplasia | The Gly380Arg mutation in FGFR3 is the genetic cause for achondroplasia (ACH), t... | BeFree | 23056398 | Detail |
0.150 | thanatophoric dysplasia | The mapping of the achondroplasia locus to the short arm of chromosome 4 and the... | BeFree | 9055906 | Detail |
0.009 | Dwarfism | The G380R mutation in the transmembrane domain of fibroblast growth factor recep... | BeFree | 21324899 | Detail |
0.457 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | The mapping of the achondroplasia locus to the short arm of chromosome 4 and the... | BeFree | 9055906 | Detail |
<0.001 | Down syndrome | FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: ph... | BeFree | 10881785 | Detail |
0.150 | thanatophoric dysplasia | Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead'... | BeFree | 12297284 | Detail |
0.621 | achondroplasia | Achondroplasia is defined by recurrent G380R mutations of FGFR3. | BeFree | 7847369 | Detail |
0.495 | Hypochondroplasia (disorder) | This assay, which is performed on the LightCycler thermocycler, enables the rapi... | BeFree | 15345118 | Detail |
0.457 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead'... | BeFree | 12297284 | Detail |
0.621 | achondroplasia | An improved tetra-primer PCR approach for the detection of the FGFR3 G380R mutat... | BeFree | 17683901 | Detail |
0.621 | achondroplasia | To determine whether the genotype could be distinguished on the basis of the phe... | BeFree | 9853502 | Detail |
0.621 | achondroplasia | Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth fact... | BeFree | 16434832 | Detail |
0.621 | achondroplasia | Achondroplasia is a skeletal dysplasia caused by substitution of arginine for gl... | BeFree | 11472579 | Detail |
0.621 | achondroplasia | In the present study, 70 of 75 Japanese patients with achondroplasia were found ... | BeFree | 10102070 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Achondroplasia | ClinVar | Detail |
NM_000142.4(FGFR3):c.[1130T>G;1138G>A] AND Achondroplasia | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Epidermal nevus | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND not provided | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND multiple conditions | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Inborn genetic diseases | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND not specified | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Hypochondroplasia | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Connective tissue disorder | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND Camptodactyly-tall stature-scoliosis-hearing loss syn... | ClinVar | Detail |
NM_000142.5(FGFR3):c.1138G>A (p.Gly380Arg) AND FGFR3-related disorder | ClinVar | Detail |
Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS-2/8) cel... | DisGeNET | Detail |
Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS-2/8) cel... | DisGeNET | Detail |
Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS-2/8) cel... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the patient with Pfeiff... | DisGeNET | Detail |
Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the patient with Pfeiff... | DisGeNET | Detail |
Gene analysis of these patients showed a T341P mutation in the FGFR2 gene in the patient with Pfeiff... | DisGeNET | Detail |
Achondroplasia, the most common form of dwarfism in man, is a dominant genetic disorder caused by a ... | DisGeNET | Detail |
A recurrent glycine to arginine mutation at codon 380 (G380R) in the transmembrane domain of the fib... | DisGeNET | Detail |
We developed a quantitative fluorescent-polymerase chain reaction (QF-PCR) method suitable for detec... | DisGeNET | Detail |
Achondroplasia is a skeletal dysplasia caused by substitution of arginine for glycine at codon 380 (... | DisGeNET | Detail |
Although not at the G1138A site, there are increased rates of other somatic mutations in the FGFR3 g... | DisGeNET | Detail |
The mother has achondroplasia and carries the common G1138 (G380R) mutation in the FGFR3 gene; the f... | DisGeNET | Detail |
The G380R mutation in FGFR3 transmembrane domain is known as the genetic cause for achondroplasia, t... | DisGeNET | Detail |
Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene. | DisGeNET | Detail |
Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resol... | DisGeNET | Detail |
FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype cor... | DisGeNET | Detail |
The father has achondroplasia due to the common G1138A (G380R) mutation in the fibroblast growth fac... | DisGeNET | Detail |
We propose that the achondroplasia mutation G380R uncouples ligand-mediated receptor activation from... | DisGeNET | Detail |
A glycine to arginine mutation at codon 380 (G380R) of the fibroblast growth factor receptor 3 gene ... | DisGeNET | Detail |
The father has achondroplasia due to the common G1138A (G380R) mutation in the fibroblast growth fac... | DisGeNET | Detail |
Rapid detection of G1138A and G1138C mutations of the FGFR3 gene in patients with achondroplasia usi... | DisGeNET | Detail |
To determine whether the genotype could be distinguished on the basis of the phenotype, we analysed ... | DisGeNET | Detail |
Achondroplasia in Sweden caused by the G1138A mutation in FGFR3. | DisGeNET | Detail |
Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead' mutant of fibroblas... | DisGeNET | Detail |
The Gly380Arg mutation in FGFR3 is the genetic cause for achondroplasia (ACH), the most common form ... | DisGeNET | Detail |
Furthermore, a G380R mutation in FGFR3 (FGFR3(Ach)), which results in achondroplasia, induces apopto... | DisGeNET | Detail |
The most common mutation for achondroplasia (FGFR3 Gly380Arg, resulting in 1138G>A) was identifie... | DisGeNET | Detail |
Our results support the argument that the G380R mutation of FGFR-3 is the most frequent mutation cau... | DisGeNET | Detail |
The most common G380R FGFR3 achondroplasia mutation was detected. | DisGeNET | Detail |
The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated re... | DisGeNET | Detail |
Down syndrome and achondroplasia were confirmed by karyotyping and presence of a common fibroblast g... | DisGeNET | Detail |
The most common achondroplasia mutation, a p.Gly380Arg in the fibroblast growth factor receptor 3 (F... | DisGeNET | Detail |
A mouse model for achondroplasia was generated by introducing the human mutation (glycine 380-argini... | DisGeNET | Detail |
The Gly380Arg mutation in FGFR3 is the genetic cause for achondroplasia (ACH), the most common form ... | DisGeNET | Detail |
The mapping of the achondroplasia locus to the short arm of chromosome 4 and the subsequent identifi... | DisGeNET | Detail |
The G380R mutation in the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) causes... | DisGeNET | Detail |
The mapping of the achondroplasia locus to the short arm of chromosome 4 and the subsequent identifi... | DisGeNET | Detail |
FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype cor... | DisGeNET | Detail |
Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead' mutant of fibroblas... | DisGeNET | Detail |
Achondroplasia is defined by recurrent G380R mutations of FGFR3. | DisGeNET | Detail |
This assay, which is performed on the LightCycler thermocycler, enables the rapid and reliable detec... | DisGeNET | Detail |
Here we compared the ubiquitylation of either wild type or a K508A 'kinase-dead' mutant of fibroblas... | DisGeNET | Detail |
An improved tetra-primer PCR approach for the detection of the FGFR3 G380R mutation responsible for ... | DisGeNET | Detail |
To determine whether the genotype could be distinguished on the basis of the phenotype, we analysed ... | DisGeNET | Detail |
Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth factor receptor 3 gene r... | DisGeNET | Detail |
Achondroplasia is a skeletal dysplasia caused by substitution of arginine for glycine at codon 380 (... | DisGeNET | Detail |
In the present study, 70 of 75 Japanese patients with achondroplasia were found to have a G1138A mut... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs28931614 dbSNP
- Genome
- hg19
- Position
- chr4:1,806,119-1,806,119
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
Genome browser